THE SURREY CARDIOVASCULAR CLINIC LTD

Company Registration Number:
05488094 (England and Wales)

Unaudited abridged accounts for the year ended 30 June 2024

Period of accounts

Start date: 01 July 2023

End date: 30 June 2024

THE SURREY CARDIOVASCULAR CLINIC LTD

Contents of the Financial Statements

for the Period Ended 30 June 2024

Balance sheet
Notes

THE SURREY CARDIOVASCULAR CLINIC LTD

Balance sheet

As at 30 June 2024


Notes

2024

2023


£

£
Called up share capital not paid: 0 0
Fixed assets
Tangible assets: 3 53,717 67,146
Total fixed assets: 53,717 67,146
Current assets
Debtors:   322,180 313,845
Cash at bank and in hand: 50,310 33,555
Total current assets: 372,490 347,400
Creditors: amounts falling due within one year:   (279,576) (173,630)
Net current assets (liabilities): 92,914 173,770
Total assets less current liabilities: 146,631 240,916
Creditors: amounts falling due after more than one year:   (62,456) (134,058)
Total net assets (liabilities): 84,175 106,858
Capital and reserves
Called up share capital: 1,960 1,960
Share premium account: 119,040 119,040
Profit and loss account: (36,825) (14,142)
Shareholders funds: 84,175 106,858

The notes form part of these financial statements

THE SURREY CARDIOVASCULAR CLINIC LTD

Balance sheet statements

For the year ending 30 June 2024 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 27 March 2025
and signed on behalf of the board by:

Name: Edward Leatham
Status: Director

The notes form part of these financial statements

THE SURREY CARDIOVASCULAR CLINIC LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

THE SURREY CARDIOVASCULAR CLINIC LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

2. Employees

2024 2023
Average number of employees during the period 25 20

THE SURREY CARDIOVASCULAR CLINIC LTD

Notes to the Financial Statements

for the Period Ended 30 June 2024

3. Tangible Assets

Total
Cost £
At 01 July 2023 458,339
Disposals (29,975)
At 30 June 2024 428,364
Depreciation
At 01 July 2023 391,193
Charge for year 13,429
On disposals (29,975)
At 30 June 2024 374,647
Net book value
At 30 June 2024 53,717
At 30 June 2023 67,146